Retracted: Decoy Oligodeoxynucleotides, Polysaccharides, and Targeted Peptide‐Functionalized Gold Nanorods for the Combined Treatment of Rheumatoid Arthritis

Nan Zhang,Shasha Zhang,Chunyu Xu,Lingling Fu,Tuanbing Liu,Yongxing Zhao
DOI: https://doi.org/10.1002/adhm.201800982
IF: 10
2018-11-04
Advanced Healthcare Materials
Abstract:Autoimmune diseases like rheumatoid arthritis (RA) possess complicated pathogenesis. Therefore, RA is hard to treat by monotherapies in clinical setting. All-in-one treatments that target inflamed joints and act efficiently are highly needed. Gold compounds are old anti-RA therapies and are fabricated into gold nanorods (GNRs) that serve as anti-RA therapeutics as well as nanocarriers for anti-inflammatory nucleic acid drug-NF-κB-decoy oligodeoxynucleotides (dODNs). A targeted peptide to vascular cell adhesion molecule-1 (VCAM-1) (PVCAM-1 ) is modified onto the GNRs to facilitate enhanced accumulation of GNRs in inflamed tissues and enhanced cellular uptake of GNRs by inflamed cells. dODNs loaded and PVCAM-1 modified GNRs (GNRs-dODN-PVCAM-1 ) are covered by polysialic acid (PSA) to protect GNRs-dODN-PVCAM-1 in vivo. Simultaneous GNRs, dODN, and thermotherapy show synergic effect on the reduction of TNF-α and IL-6 in inflamed macrophages and blood vessel cells. The simultaneous triple therapy (GNRs-dODN-PSA-PVCAM-1 +laser) demonstrates excellent anti-inflammatory efficacy in vitro and in vivo.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?